INTERNATIONAL PATENT: BLUEROCK THERAPEUTICS LP FILES APPLICATION FOR "IGFBP2 IN CELL CULTURE"

GENEVA, Aug. 12 -- BLUEROCK THERAPEUTICS LP (238 Main Street, 3rd FloorCambridge, Massachusetts 02142) filed a patent application (PCT/US2025/013871) for "IGFBP2 IN CELL CULTURE" on Jan 30, 2025. With publication no. WO/2025/166063, the details related to the patent application was published on Aug 07, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SRINIVAS, Maya (c/o BlueRock Therapeutics LP238 Main Street, 3rd FloorCambridge, Massachusetts 02142), EBEL, Mark (c/o BlueRock Therapeutics LP238 Main Street, 3rd FloorCambridge, Massachusetts 02142), WILKINSON, Dan (c/o BlueRock Therapeutics LP...